Management of Escalating Benzodiazepine Requirements in Severe Anxiety and Depression

Introduction to Benzodiazepine Management

The American College of Oncology recommends that benzodiazepines should be time-limited and are contraindicated for long-term anxiety management due to abuse potential, dependence, and cognitive impairment 1, 2, 3, 4
Guidelines explicitly warn that benzodiazepines carry increased risk of abuse and dependence and are associated with cognitive impairment 1, 2, 3
Benzodiazepines should be used only for short-term management in accordance with established psychiatric guidelines 1, 4

The American Academy of Family Physicians recommends that SSRIs (escitalopram, sertraline) or SNRIs (venlafaxine, duloxetine) are first-line treatments for both depression and anxiety disorders 8, 9
These agents treat the underlying pathophysiology rather than just symptoms, with preferred agents including escitalopram 10-20mg, sertraline 50-200mg, or venlafaxine 75-225mg 8, 9

The American College of Oncology recommends that once the antidepressant regimen is optimized and anxiety symptoms begin to improve, initiate a slow benzodiazepine taper 4, 10
Longer periods of tapering are necessary with potent or rapidly eliminated benzodiazepines like clonazepam, with a typical taper reducing by 0.125-0.25mg every 1-2 weeks, monitoring for withdrawal symptoms 4

The American College of Oncology recommends that psychological and psychosocial interventions should be derived from empirically supported treatments and are essential for long-term management 1, 2, 3
Cognitive behavioral therapy (CBT) is the psychotherapy with the highest level of evidence for anxiety disorders, and should be delivered by appropriately trained individuals 1, 2

The American College of Oncology recommends assessing compliance, adverse effects, and treatment satisfaction on a monthly basis until symptoms have subsided 4, 10
After 8 weeks, if symptom reduction is poor despite good compliance, alter the treatment course (add intervention, change medication, or refer to individual psychotherapy) 10